» Articles » PMID: 35572410

Recent Advances on Endogenous Gasotransmitters in Inflammatory Dermatological Disorders

Overview
Journal J Adv Res
Date 2022 May 16
PMID 35572410
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endogenous gasotransmitters are small gaseous mediators that can be generated endogenously by mammalian organisms. The dysregulation of the gasotransmitter system is associated with numerous disorders ranging from inflammatory diseases to cancers. However, the relevance of these endogenous gasotransmitters, prodrug donors and inhibitors in inflammatory dermatological disorders has not yet been thoroughly reviewed and discussed.

Aim Of Review: This review discusses the recent progress and will provide perspectives on endogenous gasotransmitters in the context of inflammatory dermatological disorders.

Key Scientific Concepts Of Review: Endogenous gasotransmitters nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (HS) are signaling molecules that regulate several physiological and pathological processes. In addition, sulfur dioxide (SO₂), methane (CH), hydrogen gas (H), ammonia (NH), and carbon dioxide (CO) can also be generated endogenously and may take part in physiological and pathological processes. These signaling molecules regulate inflammation, vasodilation, and oxidative stress, offering therapeutic potential and attracting interest in the field of inflammatory dermatological disorders including psoriasis, atopic dermatitis, acne, rosacea, and chronic skin ulcers. The development of effective gas donors and inhibitors is a promising alternative to treat inflammatory dermatological disorders with controllable and precise delivery in the future.

Citing Articles

Visible Tracking of Small Molecules of Gases with Fluorescent Donors.

Yu J, Xu J, Ma S, Wang C, Miao Q, Wang L Chem Biomed Imaging. 2024; 2(6):401-412.

PMID: 39474517 PMC: 11504614. DOI: 10.1021/cbmi.4c00006.


Skin-permeable gold nanoparticles with modifications azelamide monoethanolamine ameliorate inflammatory skin diseases.

Zhao H, Zhao H, Tang Y, Li M, Cai Y, Xiao X Biomark Res. 2024; 12(1):118.

PMID: 39385245 PMC: 11465885. DOI: 10.1186/s40364-024-00663-0.


Sulfenylation of ERK1/2: A novel mechanism for SO-mediated inhibition of cardiac fibroblast proliferation.

Ge M, Zhang L, Du J, Jin H, Lv B, Huang Y Heliyon. 2024; 10(14):e34260.

PMID: 39092251 PMC: 11292236. DOI: 10.1016/j.heliyon.2024.e34260.


Sulfur Dioxide Alleviates Organ Damage and Inflammatory Response in Cecal Ligation and Puncture-Induced Sepsis Rat.

Li B, Jiao K, Wang B, Gou H, Chai C, Lu Y Mol Biotechnol. 2024; .

PMID: 38829503 DOI: 10.1007/s12033-024-01168-9.


Fluorescent small molecule donors.

Chen G, Yu J, Wu L, Ji X, Xu J, Wang C Chem Soc Rev. 2024; 53(12):6345-6398.

PMID: 38742651 PMC: 11181996. DOI: 10.1039/d3cs00124e.


References
1.
Mirandola P, Gobbi G, Micheloni C, Vaccarezza M, Di Marcantonio D, Ruscitti F . Hydrogen sulfide inhibits IL-8 expression in human keratinocytes via MAP kinase signaling. Lab Invest. 2011; 91(8):1188-94. DOI: 10.1038/labinvest.2011.76. View

2.
Wang B, Ou-Yang J . Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc Drug Rev. 2005; 23(2):161-72. DOI: 10.1111/j.1527-3466.2005.tb00163.x. View

3.
Wang B, Ouyang J, Liu Y, Yang J, Wei L, Li K . Sodium ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits. J Cardiovasc Pharmacol. 2004; 43(4):549-54. DOI: 10.1097/00005344-200404000-00010. View

4.
Ying J, Wang Q, Jiang M, Wang X, Liu W, Wang X . Hydrogen Sulfide Promotes Cell Proliferation and Melanin Synthesis in Primary Human Epidermal Melanocytes. Skin Pharmacol Physiol. 2020; 33(2):61-68. DOI: 10.1159/000506818. View

5.
Medina M, Sapochnik D, Garcia Sola M, Coso O . Regulation of the Expression of Heme Oxygenase-1: Signal Transduction, Gene Promoter Activation, and Beyond. Antioxid Redox Signal. 2019; 32(14):1033-1044. PMC: 7153632. DOI: 10.1089/ars.2019.7991. View